Evidence map›Paper›PMID 37766192›Full record

ReviewViruses2023

Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context.

Bruno Pozzetto, Gilda Grard, Guillaume Durand, Marie-Claire Paty, Pierre Gallian, Sophie Lucas-Samuel, Stéphanie Diéterlé, Muriel Fromage, Marc Durand, Didier Lepelletier and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Seroprevalence of West Nile virus among blood donors in mainland France, 2021 to 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Bruno PozzettoHaut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France.ORCID 0000-0002-2603-8467
Gilda GrardNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France.
Guillaume DurandNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France.ORCID 0000-0003-3348-9618
Marie-Claire PatySanté Publique France, The French Public Health Agency, 94410 Saint-Maurice, France.
Pierre GallianEtablissement Français du Sang, 93218 Saint-Denis, France.
Sophie Lucas-SamuelAgence de la Biomédecine, 93212 Saint-Denis, France.
Stéphanie DiéterléAgence de la Biomédecine, 93212 Saint-Denis, France.
Muriel FromageAgence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 93200 Saint-Denis, France.
Marc DurandHaut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France.
Didier LepelletierHaut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France.
Christian ChidiacHaut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France.
Bruno HoenHaut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France.ORCID 0000-0003-3070-3017
Xavier Nicolas de LamballerieNational Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France.
Inserm · FRAgence de la Biomédecine · FRAgence Nationale de Sécurité du Médicament et des Produits de Santé · FRCentre Hospitalier Régional et Universitaire de Nancy · FRHospices Civils de Lyon · FRSanté Publique France · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diseases caused by arboviruses are on the increase worldwide. In addition to arthropod bites, most arboviruses can be transmitted via accessory routes. Products of human origin (labile blood products, solid organs, hematopoietic stem cells, tissues) present a risk of contamination for the recipient if the donation is made when the donor is viremic. Mainland France and its overseas territories are exposed to a complex array of imported and endemic arboviruses, which differ according to their respective location. This narrative review describes the risks of acquiring certain arboviral diseases from human products, mainly solid organs and hematopoietic stem cells, in the French context. The main risks considered in this study are infections by West Nile virus, dengue virus, and tick-borne encephalitis virus. The ancillary risks represented by Usutu virus infection, chikungunya, and Zika are also addressed more briefly. For each disease, the guidelines issued by the French High Council of Public Health, which is responsible for mitigating the risks associated with products of human origin and for supporting public health policy decisions, are briefly outlined. This review highlights the need for a "One Health" approach and to standardize recommendations at the international level in areas with the same viral epidemiology.

Indexed as

ArbovirusesChikungunya FeverZika VirusZika Virus InfectionDrug ContaminationHematopoietic Stem CellsHumansPublic Healthchikungunya virusdengue virusFrancehematopoietic stem cellproducts of human originsolid organtick-borne encephalitis virusUsutu virusWest Nile virusZika virus

Identifiers

PMID37766192
PMCPMC10536626
OpenAlexW4386073086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.